Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 301–400 of 1,008
Scheinfeld, M. H., Roncarati, R., Vito, P., Lopez, P. A., Abdallah, M., & D'Adamio, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108357200 · Cited by 159
Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases
Lemberg, M. K., Menendez, J., Misik, A., Garcia, M., Koth, C. M., & Freeman, M. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600537 · Cited by 160
“The second family is a group of aspartyl proteases including g-secretase (De Strooper et al, 1998; Steiner et al, 1999; Wolfe et al, 1999) and signal peptide peptidase (SPP) (Ponting et al, 2002; Weihofen et al, 2002).”
BackgroundAlzheimer’s disease and hippocampal adult neurogenesis; exploring shared mechanisms
Hollands, C., Bartolotti, N., & Lazarov, O. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00178 · Cited by 160
Presenilins and Alzheimer’s disease: biological functions and pathogenic mechanisms
Czech, C., Tremp, G., & Pradier, L. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00033-7 · Cited by 158
Murphy, M. P., Hickman, L. J., Eckman, C. B., Uljon, S. N., Wang, R., & Golde, T. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11914 · Cited by 157
Kumar-Singh, S. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.18.2589 · Cited by 158
Self-citationFlavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
Rezai‐Zadeh, K., Douglas Shytle, R., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D., Town, T., & Tan, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 153
“Intracellularly, -CTF is then cleaved by a multi-protein -secretase complex that results in generation of the A peptide and a smaller -CTF, also known as C57 [16, 17].”
BackgroundMature Glycosylation and Trafficking of Nicastrin Modulate Its Binding to Presenilins
Yang, D.-S., Tandon, A., Chen, F., Yu, G., Yu, H., Arawaka, S., Hasegawa, H., Duthie, M., Schmidt, S. D., Ramabhadran, T. V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110871200 · Cited by 157
Cryo-EM structure of gamma secretase in complex with a Notch fragment: 6idf
Yang, G., Zhou, R., Zhou, Q., Guo, X., Yan, C., Ke, M., Lei, J., & Shi, Y. (2018) · Worldwide Protein Data Bank · doi:10.2210/pdb6idf/pdb · Cited by 154
The involvement of lipid rafts in Alzheimer's disease (Review)
Cordy, J. M., Cordy, J. M., Hooper, N. M., & Turner, A. J. (2006) · Molecular Membrane Biology · doi:10.1080/09687860500496417 · Cited by 157
“…of the membranebound C-terminal fragment to release Ab. g-Secretase activity is known to be closely associated with the presenilin (PS) proteins (De Strooper et al. 1998; Wolfe et al. 1999), and it has been demon- strated that at least three other proteins, nicastrin, aph-1 and pen-2, are required…”
BackgroundRegulated Intramembrane Proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b
Martin, L., Fluhrer, R., Reiss, K., Kremmer, E., Saftig, P., & Haass, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706661200 · Cited by 155
Gu, Y., Chen, F., Sanjo, N., Kawarai, T., Hasegawa, H., Duthie, M., Li, W., Ruan, X., Luthra, A., Mount, H. T. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209499200 · Cited by 149
Vitamin A and Alzheimer's disease
Ono, K., & Yamada, M. (2012) · Geriatrics & Gerontology International · doi:10.1111/j.1447-0594.2011.00786.x · Cited by 151
Inflammatory aspects of Alzheimer’s disease
Lucena, P. B., & Heneka, M. T. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02790-2 · Cited by 166
“EOAD mutations in APP and PS1/2 alter Aβ biogenesis, resulting in an altered formation of amyloidogenic Aβ peptides [43, 52, 91, 152, 172, 240, 249].”
Qualitative changes in human γ-secretase underlie familial Alzheimer’s disease
Szaruga, M., Veugelen, S., Benurwar, M., Lismont, S., Sepulveda-Falla, D., Lleo, A., Ryan, N. S., Lashley, T., Fox, N. C., Murayama, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150892 · Cited by 155
“PSEN is the catalytic subunit of the γ-secretase complex (De Strooper et al., 1998; Wolfe et al., 1999), an intramembrane multimeric protease involved in the processing of many type 1 transmembrane proteins; among them, the Notch receptors and APP have received much attention be- cause of their…”
BackgroundPartial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
Farmery, M. R., Tjernberg, L. O., Pursglove, S. E., Bergman, A., Winblad, B., & Näslund, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211992200 · Cited by 153
Presenilin-dependent γ-secretase activity modulates thymocyte development
Doerfler, P., Shearman, M. S., & Perlmutter, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161102498 · Cited by 152
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 150
Zatti, G., Burgo, A., Giacomello, M., Barbiero, L., Ghidoni, R., Sinigaglia, G., Florean, C., Bagnoli, S., Binetti, G. G., Sorbi, S., et al. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.03.002 · Cited by 170
Teo, J.-L., Ma, H., Nguyen, C., Lam, C., & Kahn, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504600102 · Cited by 152
Zhao, G., Mao, G., Tan, J., Dong, Y., Cui, M.-Z., Kim, S.-H., & Xu, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400473200 · Cited by 150
Beglopoulos, V., Sun, X., Saura, C. A., Lemere, C. A., Kim, R. D., & Shen, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409544200 · Cited by 154
The Genetics of the Amyloidoses
Buxbaum, J. N., & Tagoe, C. E. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.543 · Cited by 173
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
Physiology and pharmacology of amyloid precursor protein
Cho, Y., Bae, H.-G., Okun, E., Arumugam, T. V., & Jo, D.-G. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108122 · Cited by 142
Presenilin function and γ‐secretase activity
Brunkan, A. L., & Goate, A. M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03099.x · Cited by 145
“PS1–/– mice also have defects reminiscent of Notch–/– phenotypes (Shen et al. 1997; Wong et al. 1997; De Strooper et al. 1998) and re-introduction of wtPS1 or FAD mutant PS1 rescues the lethality of the PS1 knockout mouse (Davis et al. 1998; Qian et al. 1998).”
BackgroundInfluentialLandman, N., Jeong, S. Y., Shin, S. Y., Voronov, S. V., Serban, G., Kang, M. S., Park, M. K., Di Paolo, G., Chung, S., & Kim, T.-W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604954103 · Cited by 149
Potential Bidirectional Relationship Between Periodontitis and Alzheimer’s Disease
Liccardo, D., Marzano, F., Carraturo, F., Guida, M., Femminella, G. D., Bencivenga, L., Agrimi, J., Addonizio, A., Melino, I., Valletta, A., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00683 · Cited by 157
Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila
Chung, H.-M., & Struhl, G. (2001) · Nature Cell Biology · doi:10.1038/ncb1201-1129 · Cited by 164
Secretase inhibitors and modulators for Alzheimer’s disease treatment
Tomita, T. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.24 · Cited by 146
Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch
Capell, A., Steiner, H., Romig, H., Keck, S., Baader, M., Grim, M. G., Baumeister, R., & Haass, C. (2000) · Nature Cell Biology · doi:10.1038/35008626 · Cited by 166
Transgenic mouse models of Alzheimer's disease: phenotype and application.
(2003) · PubMed · doi:10.1097/01.fbp.0000088420.18414.ff · Cited by 147
“reduced in PS1-deficient cells and completely absent from PS1/PS2-deficient cells (DeStrooper et al., 1998; Herreman et al., 2000).”
BackgroundProcessing of β-Secretase by Furin and Other Members of the Proprotein Convertase Family
Creemers, J. W. M., Ines Dominguez, D., Plets, E., Serneels, L., Taylor, N. A., Multhaup, G., Craessaerts, K., Annaert, W., & De Strooper, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006947200 · Cited by 147
Self-citationAlzheimer's Disease and the Amyloid β Protein: What Is the Role of Amyloid ?
Small, D. H., & McLean, C. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730443.x · Cited by 143
The unfolded protein response and Alzheimer’s disease
Imaizumi, K., Miyoshi, K., Katayama, T., Yoneda, T., Taniguchi, M., Kudo, T., & Tohyama, M. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(01)00049-7 · Cited by 144
Activation and intrinsic γ-secretase activity of presenilin 1
Ahn, K., Shelton, C. C., Tian, Y., Zhang, X., Gilchrist, M. L., Sisodia, S. S., & Li, Y.-M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013246107 · Cited by 139
Protein Accumulation in Traumatic Brain Injury
Smith, D. H., Uryu, K., Saatman, K. E., Trojanowski, J. Q., & McIntosh, T. K. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:59 · Cited by 160
“In AD, the primary mechanism for production of Aβ peptides is thought to be via transmembrane cleavage of APP by β- and γ-secretases (De Strooper et al., 1998; Vassar et al., 1999; Selkoe and Wolfe, 2000; Nunan and Small, 2000; Esler and Wolfe, 2001).”
BackgroundInhibition and Modulation of γ-Secretase for Alzheimer's Disease
Wolfe, M. S. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.010 · Cited by 143
“The first was the finding that knockout of presenilin-1 dramatically reduces A production at the level of -secretase.(17) Later stud-”
A cut short to death: Parl and Opa1 in the regulation of mitochondrial morphology and apoptosis
Pellegrini, L., & Scorrano, L. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402145 · Cited by 160
“The second family includes aspartic proteases, whose prototypic members are the presenilins (PSs) involved in cleavage of the amyloid b protein precursor (AbPP) and Notch.(70,71) This family also includes the signal peptide peptidase, which catalyses intramembrane proteolysis of signal sequence remnants and possibly a…”
Perturbed Neurogenesis in the Adult Hippocampus Associated with Presenilin-1 A246E Mutation
Chevallier, N. L., Soriano, S., Kang, D. E., Masliah, E., Hu, G., & Koo, E. H. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62962-8 · Cited by 153
“PS1-dependent -secretase activity generates the active form of Notch, NICD, among a burgeoning list of membrane protein substrates.(7,24,25) Impaired Notch signaling is the likely explanation of altered neurogenesis in PS1 null embryos.”
BackgroundHaass, C., & Selkoe, D. (2022) · PLOS Biology · doi:10.1371/journal.pbio.3001694 · Cited by 145
“But how do these mutations affect APP processing so selectively? It turned out that PS1 and PS2 encode the catalytically active subunit of γ-secretase [26,27], the protease that effects APP carboxyl-terminal cleavage and thus the final liberation of Aβ.”
BackgroundA fast growing spectrum of biological functions of γ-secretase in development and disease
Jurisch‐Yaksi, N., Sannerud, R., & Annaert, W. G. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.016 · Cited by 165
Self-citationRhomboid Proteases and their Biological Functions
Freeman, M. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091628 · Cited by 156
“Four classes of intramembrane proteases have been discovered: metalloproteases, exemplified by the site-2 protease family (2, 22, 66); aspartyl proteases, of which there are two classes, gamma secretases and the signal peptide peptidase-like family (19, 26, 31, 60, 89, 90); and the rhomboid-like family, which are seri…”
BackgroundO-GlcNAcylation and neurodegeneration
Wani, W. Y., Chatham, J. C., Darley-Usmar, V. M., McMahon, L. L., & Zhang, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.08.002 · Cited by 156
Presenilins: molecular switches between proteolysis and signal transduction
Annaert, W. G., & Strooper, B. D. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01455-1 · Cited by 161
Self-citationTian, G., Sobotka‐Briner, C. D., Zysk, J. R., Liu, X. F., Birr, C., Sylvester, M. A., Edwards, P. D., Scott, C. D., & Greenberg, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112328200 · Cited by 149
Alzheimer’s disease and Notch signaling
Woo, H., Park, J. S., Gwon, A., Arumugam, T. V., & Jo, D. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.093 · Cited by 148
Presenilin-mediated transmembrane cleavage is required for Notch signal transduction in Drosophila
Struhl, G., & Greenwald, I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.229 · Cited by 140
Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches
Wellington, C. L., & Hayden, M. R. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.570101.x · Cited by 141
CD74 Is a Member of the Regulated Intramembrane Proteolysis-processed Protein Family
Becker-Herman, S., Arie, G., Medvedovsky, H., Kerem, A., & Shachar, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-04-0327 · Cited by 141
“CD74 and the RIP-processed Protein Family Vol. 16, November 2005 5065 PS-dependent processing of APP (De Strooper et al., 1998; Naruse et al., 1998), CD44 (Lammich et al., 2002; Murakami et al., 2003), ErbB-4 (Ni et al., 2001), E-cadherin (Marambaud et al., 2002), and Notch (Lammich et al., 2002).”
BackgroundPaul, S. (2008) · BioEssays · doi:10.1002/bies.20852 · Cited by 157
Pinnix, I., Musunuru, U., Tun, H., Sridharan, A., Golde, T., Eckman, C., Ziani-Cherif, C., Onstead, L., & Sambamurti, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005968200 · Cited by 140
Pellegrini, L., Passer, B. J., Tabaton, M., Ganjei, J. K., & D'Adamio, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21011 · Cited by 139
γ‐Secretase inhibitors and modulators for Alzheimer’s disease
Wolfe, M. S. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07501.x · Cited by 134
How intramembrane proteases bury hydrolytic reactions in the membrane
Erez, E., Fass, D., & Bibi, E. (2009) · Nature · doi:10.1038/nature08146 · Cited by 169
Smith, I. F., Green, K. N., & LaFerla, F. M. (2005) · Cell Calcium · doi:10.1016/j.ceca.2005.06.021 · Cited by 149
Genetics of Alzheimer’s Disease
Vilatela, M. E. A., López, M., & Yescas, P. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.017 · Cited by 165
Tan, J. Z. A., & Gleeson, P. A. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2018.11.013 · Cited by 124
Tolia, A., Chávez-Gutiérrez, L., & De Strooper, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604997200 · Cited by 134
Biochemistry and Molecular Biology of Amyloid β‐Protein and the Mechanism of Alzheimer's Disease
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)01223-7 · Cited by 137
Hartmann, D., Strooper, B. D., & Säftig, P. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80331-5 · Cited by 151
“This indicates that PS1 deficiency leads to selective inhibition of APP cleavage by γ-secretase, which normally generates the carboxy terminus of the β-A4-peptide [13].”
InfluentialSchneider, I., Reversé, D., Dewachter, I., Ris, L., Caluwaerts, N., Kuipéri, C., Gilis, M., Geerts, H., Kretzschmar, H., Godaux, E., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010977200 · Cited by 136
Wiltfang, J., Esselmann, H., Cupers, P., Neumann, M., Kretzschmar, H., Beyermann, M., Schleuder, D., Jahn, H., Rüther, E., Kornhuber, J., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102790200 · Cited by 126
Self-citationXia, W., Ray, W. J., Ostaszewski, B. L., Rahmati, T., Kimberly, W. T., Wolfe, M. S., Zhang, J., Goate, A. M., & Selkoe, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9299 · Cited by 133
Presenilin-dependent γ-Secretase Processing Regulates Multiple ERBB4/HER4 Activities
Vidal, G. A., Naresh, A., Marrero, L., & Jones, F. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412457200 · Cited by 133
Wakabayashi, T., Craessaerts, K., Bammens, L., Bentahir, M., Borgions, F., Herdewijn, P., Staes, A., Timmerman, E., Vandekerckhove, J., Rubinstein, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1978 · Cited by 135
Self-citationGenetic markers for diagnosis and pathogenesis of Alzheimer's disease
Kim, D., Yeo, S. H., Park, J.-M., Choi, J. Y., Lee, T.-H., Park, S. Y., Ock, M. S., Eo, J., Kim, H., & Cha, H. (2014) · Gene · doi:10.1016/j.gene.2014.05.031 · Cited by 146
Sato, N., Urano, F., Leem, J. Y., Kim, S., Li, M., Donoviel, D. B., Bernstein, A., Lee, A. S., Ron, D., Veselits, M., et al. (2000) · Nature Cell Biology · doi:10.1038/35046500 · Cited by 144
Variations in the neuropathology of familial Alzheimer’s disease
Shepherd, C. E., McCann, H., & Halliday, G. M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0521-4 · Cited by 163
Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential
Wolfe, M. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0004897 · Cited by 133
NFκB-dependent Control of BACE1 Promoter Transactivation by Aβ42
Buggia-Prevot, V., Sevalle, J., Rossner, S., & Checler, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706579200 · Cited by 125
Cai, D., Leem, J. Y., Greenfield, J. P., Wang, P., Kim, B. S., Wang, R., Lopes, K. O., Kim, S.-H., Zheng, H., Greengard, P., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209065200 · Cited by 118
Stabler, S. M., Ostrowski, L. L., Janicki, S. M., & Monteiro, M. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.6.1277 · Cited by 146
“The FAD-linked PS mutations are thought to confer some unknown detrimental gain of function which correlates with altered b APP processing (see Davis et al., 1998; De Strooper et al., 1998; Qian et al., 1998).”
BackgroundSiman, R., Reaume, A. G., Savage, M. J., Trusko, S., Lin, Y.-G., Scott, R. W., & Flood, D. G. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08717.2000 · Cited by 133
The Role of Presenilins in γ-Secretase Activity
Wolfe, M. S., & Haass, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000026200 · Cited by 132
Simões, A. E., Pereira, D. M., Amaral, J. D., Nunes, A. F., Gomes, S. E., Rodrigues, P. M., Lo, A. C., D'Hooge, R., Steer, C. J., Thibodeau, S. N., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-181 · Cited by 124
“In AD, Aβ peptides are generated by successive proteolysis of APP that is initially cleaved by β-secretase, and subsequently by γ-secretase [31-33].”
BackgroundGrimm, M. O. W., Grimm, H. S., Tomic, I., Beyreuther, K., Hartmann, T., & Bergmann, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801520200 · Cited by 128
Barnes, N. Y., Li, L., Yoshikawa, K., Schwartz, L. M., Oppenheim, R. W., & Milligan, C. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05869.1998 · Cited by 131
“…of APP and subsequent generation of A is a very early event in the development of Alzheimer's disease (AD) (for excellent review, see Selkoe, 1993; Yankner, 1996), recent reports suggest that the protein biology of this disease is very complex (De Strooper et al., 1998; Haass and Selkoe, 1998).”
Steiner, H., Romig, H., Grim, M. G., Philipp, U., Pesold, B., Citron, M., Baumeister, R., & Haass, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7615 · Cited by 127
Treatment Strategies Targeting Amyloid -Protein
Schenk, D., Basi, G. S., & Pangalos, M. N. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006387 · Cited by 126
“…conclusive evidence to settle the argument, based on reverse genetic approaches supporting PS1 and PS2 as a critical component of g-secretase (De Strooper et al. 1998; Herreman et al. 1999, 2000; Steiner et al. 1999), that two transmembrane aspartyl residues in the presenilin amino-terminal…”
BackgroundPresenilins: Members of the γ-Secretase Quartets, But Part-Time Soloists Too
Wakabayashi, T., & De Strooper, B. (2008) · Physiology · doi:10.1152/physiol.00009.2008 · Cited by 123
“The finding that genetic inactivation of presenilin 1 led to almost complete loss of A peptide generation in neurons provided the first clear evidence that presenilins constitute an essential part of -secretase activity (11) and was an important step toward the progressive molecular dissection of the -secretase comple…”
BackgroundBroersen, K., Jonckheere, W., Rozenski, J., Vandersteen, A., Pauwels, K., Pastore, A., Rousseau, F., & Schymkowitz, J. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzr020 · Cited by 126
“Ab peptides are generated from amyloid precursor protein as a result of sequential b-secretase and g-secretase proteolytic activity (De Strooper et al., 1998; Vassar et al., 1999; Wolfe et al., 1999).”
BackgroundWeggen, S., Eriksen, J. L., Sagi, S. A., Pietrzik, C. U., Golde, T. E., & Koo, E. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304824200 · Cited by 127
Alzheimer disease: Amyloidogenesis, the presenilins and animal models
Newman, M., Musgrave, I., & Lardelli, M. T. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.001 · Cited by 157
“peptides [58-60] and there is a reduction in γ-secretase cleavage of APP in neuronal cultures derived from PS1 deficient mice embryos [61].”
BackgroundGenetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene
Bagaria, J., Bagyinszky, E., & An, S. S. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810970 · Cited by 112
“A deficiency in PSEN1 function may impair APP processing, resulting in altered amyloid peptide production [11].”
BackgroundSai, X., Kawamura, Y., Kokame, K., Yamaguchi, H., Shiraishi, H., Suzuki, R., Suzuki, T., Kawaichi, M., Miyata, T., Kitamura, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112372200 · Cited by 129
Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance
Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127
Nicastrin binds to membrane-tethered Notch
Chen, F., Yu, G., Arawaka, S., Nishimura, M., Kawarai, T., Yu, W. H., Tandon, A., Supala, A., Song, Y., Rogaeva, E. A., et al. (2001) · Nature Cell Biology · doi:10.1038/35087069 · Cited by 141
Neuronal death in Alzheimer’s disease and therapeutic opportunities
Donev, R., Kolev, M., Millet, B., & Thome, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00889.x · Cited by 126
“Experiments with animal models lacking expression of either PS1 or PS2 showed that between the two presenilins PS1 plays a major role regulating the activity of -secretase and thus A formation [50, 51].”
BackgroundInsights into T‐cell dysfunction in Alzheimer's disease
Dai, L., & Shen, Y. (2021) · Aging Cell · doi:10.1111/acel.13511 · Cited by 117
Assembly, Maturation, and Trafficking of the γ-Secretase Complex in Alzheimers Disease
Dries, D., & Yu, G. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954695 · Cited by 122
Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling
Strickland, D. K., & Ranganathan, S. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00330.x · Cited by 145
Role of Calcium Homeostasis in Alzheimer’s Disease
Ge, M., Zhang, J., Chen, S., Huang, Y., Chen, W., He, L., & Zhang, Y. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s350939 · Cited by 124
“Presenilin1 (PS1) is involved in γ-secretase-mediated proteolytic cleavage of the C-terminal transmembrane fragments of APP after their generation by α- and β-secretase(s).(30) PS1 mutation, accounting for more than 80% of the total known FAD-causing mutations,(31) leads to increased intracellular calcium through diff…”
BackgroundAlzheimer’s disease due to loss of function: A new synthesis of the available data
Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 124
Structure and Function of the γ-Secretase Complex
Wolfe, M. S. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00401 · Cited by 116
Lovastatin enhances Aβ production and senile plaque deposition in female Tg2576 mice
Park, I.-H., Hwang, E. M., Hong, H., Boo, J. H., Oh, S. S., Lee, J., Jung, M. W., Bang, O. Y., Kim, S. U., & Mook‐Jung, I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00155-0 · Cited by 135
Drosophila Nicastrin Is Essential for the Intramembranous Cleavage of Notch
López‐Schier, H., & Johnston, D. S. (2002) · Developmental Cell · doi:10.1016/s1534-5807(01)00109-5 · Cited by 127
Okochi, M., Tagami, S., Yanagida, K., Takami, M., Kodama, T. S., Mori, K., Nakayama, T., Ihara, Y., & Takeda, M. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.11.028 · Cited by 123
“Because Ab is secreted as multiple peptide species with different C termini, intramembrane proteolysis of Ab by presenilin (PS)/gsecretase (De Strooper et al., 1998, 1999; Sherrington et al., 1995; Struhl and Greenwald, 1999; Wolfe et al., 1999) does not occur at a unique site.”
BackgroundCharacterization of sequential N-cadherin cleavage by ADAM10 and PS1
Uemura, K., Kihara, T., Kuzuya, A., Okawa, K., Nishimoto, T., Ninomiya, H., Sugimoto, H., Kinoshita, A., & Shimohama, S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.04.018 · Cited by 135
Mudher, A., Chapman, S., Richardson, J., Asuni, A., Gibb, G., Pollard, C., Killick, R., Iqbal, T., Raymond, L., Varndell, I., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-04987.2001 · Cited by 121
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.